Is full-automation in radiotherapy treatment planning ready for take off?

Automation Human oversight Treatment planning

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
24 Sep 2024
Historique:
received: 29 04 2024
revised: 03 09 2024
accepted: 23 09 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 26 9 2024
Statut: aheadofprint

Résumé

Radiotherapy treatment planning is undergoing a transformation with the increasing integration of automation. This transition draws parallels with the aviation industry, which has a long-standing history of addressing challenges and opportunities introduced by automated systems. Both fields witness a shift from manual operations to systems capable of operating independently, raising questions about the risks and evolving role of humans within automated workflows. In response to this shift, a working group assembled during the ESTRO Physics Workshop 2023, reflected on parallels to draw lessons for radiotherapy. A taxonomy is proposed, leveraging insights from aviation, that outlines the observed levels of automation within the context of radiotherapy and their corresponding implications for human involvement. Among the common identified risks associated with automation integration are complacency, overreliance, attention tunneling, data overload, a lack of transparency and training. These risks require mitigation strategies. Such strategies include ensuring role complementarity, introducing checklists and safety requirements for human-automation interaction and using automation for cognitive unload and workflow management. Focusing on already automated processes, such as dose calculation and auto-contouring as examples, we have translated lessons learned from aviation. It remains crucial to strike a balance between automation and human involvement. While automation offers the potential for increased efficiency and accuracy, it must be complemented by human oversight, expertise, and critical decision-making. The irreplaceable value of human judgment remains, particularly in complex clinical situations. Learning from aviation, we identify a need for human factors engineering research in radiation oncology and a continued requirement for proactive incident learning.

Identifiants

pubmed: 39326522
pii: S0167-8140(24)03524-2
doi: 10.1016/j.radonc.2024.110546
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

110546

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dylan Callens (D)

Laboratory of Experimental Radiotherapy, Catholic University of Leuven, Leuven, Belgium; Department of Radiation Oncology, University Hospitals of Leuven, Leuven, Belgium.

Ciaran Malone (C)

St.Luke's Radiation Oncology Network, Dublin, Ireland.

Antony Carver (A)

Department of Medical Physics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Christian Fiandra (C)

Department of Oncology, University of Turin, Turin, Italy.

Mark J Gooding (MJ)

Inpictura Ltd, Abingdon, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Stine S Korreman (SS)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.

Joana Matos Dias (J)

Faculty of Economics and INESC Coimbra, University of Coimbra, Coimbra, Portugal.

Richard A Popple (RA)

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.

Humberto Rocha (H)

CeBER, Faculty of Economics, University of Coimbra, Coimbra, Portugal.

Wouter Crijns (W)

Laboratory of Experimental Radiotherapy, Catholic University of Leuven, Leuven, Belgium; Department of Radiation Oncology, University Hospitals of Leuven, Leuven, Belgium.

Carlos E Cardenas (CE)

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.

Classifications MeSH